通过药理动力学-药理动力学建模,量化甲酸对银病中阿达利穆马布反应的影响
Astrid van Huizen1, Paul Bank2, Gayle van der Kraaij1
1Amsterdam Public Health, Infection and Immunity, Department of Dermatology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
The Journal of investigative dermatology
|November 22, 2023
概括
在牛皮患者中,将甲状腺素与阿达利姆巴治疗结合使用可能会提高药物的疗效. 甲托雷克萨特联合治疗与降低的抗药抗体和可能更好的阿达利穆马布的药理动力学/药理动力学 (PK/PD) 相关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 阿达利穆马布是一种治疗牛皮的生物疗法.
- 抗药抗体 (ADA) 可以降低阿达利穆马布的疗效.
- 甲托雷克萨特是治疗牛皮的常见并发药物.
研究的目的:
- 量化阿达利木马布的药理动力学/药理动力学 (PK/PD).
- 评估甲状腺素联合治疗对阿达利木巴PK/PD和ADA发展的影响.
- 评估甲状腺素,ADAs和阿达利穆马布疗效之间的关系.
主要方法:
- 在49周内使用59名牛皮患者的前性数据进行人口PK-PD建模.
- 分析患者数据,包括银病区域和严重性指数 (PASI) 评分,阿达利穆马布血清度和ADA标位.
- 共同变量分析以确定影响PK/PD变异性的因素,包括甲状腺素使用.
主要成果:
- 与单独服用阿达利穆巴布 (46.7%) 相比,在接受阿达利穆巴布加上甲铁酸 (38.7%) 的患者中,ADA的发展较低.
- ADA的存在与增加的阿达利穆马布表面清除相关.
- 同时使用甲状腺素与半最大抑制度的降低有关,这表明药物活性有所改善.
结论:
- 同时使用甲状腺素可以间接增加阿达利穆马布的度和有效性在牛皮患者.
- 这种效应可能部分由减少的ADA形成来调节.
- 这些发现支持将美托特雷克萨特与阿达利穆马布结合用于治疗牛皮的好处.
相关概念视频
01:20Pharmacokinetic Models: Overview
717
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
717
01:26Pharmacokinetic Models: Comparison and Selection Criterion
78
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
78
01:12Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
41
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
41
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
73
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
73
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
138
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
138